163 related articles for article (PubMed ID: 6659078)
1. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
Pozdniakova TM; Rybachuk VN; Vovk EV
Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
[TBL] [Abstract][Full Text] [Related]
2. [Effect of peptides--structural analogs of NH2-terminal sites of fibrin alpha- and beta-chains--on specific binding of the NH2-terminal disulfide bond of fibrin with fibrinogen].
Pozdniakova TM; Rybalchuk VN; Il'ina AV; Davidovich IuA; Rogozhin SV
Ukr Biokhim Zh (1978); 1986; 58(2):10-5. PubMed ID: 3509954
[TBL] [Abstract][Full Text] [Related]
3. [The role of D2-E2 centers of interdomain binding of fibrin monomer during fibrinogen co-polymerization with an NH2-terminal disulfide knot of fibrin].
Pozdniakova TM; Rybachuk VN; Ugarova TP
Biokhimiia; 1987 Apr; 52(4):592-8. PubMed ID: 3593791
[TBL] [Abstract][Full Text] [Related]
4. [Complexes of the N-terminal disulfide branch point of fibrin with fibrinogen].
Pozdniakova TM; Rybachuk VN
Ukr Biokhim Zh (1978); 1985; 57(1):3-8. PubMed ID: 3976012
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of functioning of specific sites of interdomain D-E binding of fibrin molecules: interaction of fibrinogen with the N-terminal disulfide node of fibrin].
Rybachuk VN; Pozdniakova TM
Ukr Biokhim Zh (1978); 1986; 58(4):3-9. PubMed ID: 3739028
[TBL] [Abstract][Full Text] [Related]
6. [Differences between the complexes formed by monomeric fibrin with fragment D and dimer D].
Belitser VA; Platonova TN; Pozdniakova TM
Ukr Biokhim Zh (1978); 1983; 55(3):243-9. PubMed ID: 6868146
[TBL] [Abstract][Full Text] [Related]
7. [Plasminogen activation by a tissue activator and effector properties of fibrinogen-N-terminal disulfide (N-DSK) fibrin complex].
Makogonenko EM; Druzhina NN; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
Ukr Biokhim Zh (1978); 1991; 63(3):17-23. PubMed ID: 1926582
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition].
Platonova TN; Musialkovskaia AA; Tolstykh VM; Belitser VA
Biokhimiia; 1980 Oct; 45(10):1780-7. PubMed ID: 7236767
[TBL] [Abstract][Full Text] [Related]
9. The N-DSK gamma-chain binds to immunoprecipitated GP IIb-IIIa.
Thorsen LI; Hessel B; Brosstad F; Gogstad G; Solum NO
Thromb Res; 1987 Aug; 47(3):315-21. PubMed ID: 3629559
[TBL] [Abstract][Full Text] [Related]
10. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the iodination of tyrosines in the amino terminal domain of fibrinogen and in N-DSK and fibrin-N-DSK.
York JL
Thromb Res; 1983 Jul; 31(2):203-9. PubMed ID: 6636042
[TBL] [Abstract][Full Text] [Related]
12. Orientation of the carboxy-terminal regions of fibrin gamma chain dimers determined from the crosslinked products formed in mixtures of fibrin, fragment D, and factor XIIIa.
Siebenlist KR; Meh DA; Wall JS; Hainfeld JF; Mosesson MW
Thromb Haemost; 1995 Oct; 74(4):1113-9. PubMed ID: 8560422
[TBL] [Abstract][Full Text] [Related]
13. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
Cierniewski CS; Kloczewiak M; Budzynski AZ
J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
[TBL] [Abstract][Full Text] [Related]
14. Distinctive role of histidine-16 of the B beta chain of fibrinogen in the end-to-end association of fibrin.
Shimizu A; Saito Y; Inada Y
Proc Natl Acad Sci U S A; 1986 Feb; 83(3):591-3. PubMed ID: 3456154
[TBL] [Abstract][Full Text] [Related]
15. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
Pozdniakova TM; Rybachuk VN; Vovk Ev
Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
[TBL] [Abstract][Full Text] [Related]
17. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
Kinjoh K; Nakamura M; Sunagawa M; Kosugi T
Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of the formation of complexes between monomer fibrin and the inhibitor of its polymerization - fragment D].
Belitser VA; Pozdniakova TM; Vovk EV; Rybachuk VN
Biokhimiia; 1983 Jan; 48(1):125-31. PubMed ID: 6830911
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
[TBL] [Abstract][Full Text] [Related]
20. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
